Trials / Withdrawn
WithdrawnNCT01565070
Osteoarthritis in Older Adults: Recovery of Mobility and Pain With a Topical Analgesic
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Chile · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Biofreeze® is a topical ointment that has menthol and alcamphor. Its analgesic effect lies in the stimulation of A and C fibers by cold and nociceptive stimulation, respectively, which is produced by menthol, apparently through the newly discovered receptor TRPM8 (Transient Receptor Potential melastatin-8) The aim of this study is to investigate if BIOFREEZE ® treatment (Performance Health Inc., Export, PA) improves symptoms associated with moderate knee osteoarthritis, which would decrease the immobility and isolation in older adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Biofreeze | Use of Biofreeze ointment |
| OTHER | Placebo | Use of placebo ointment |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2012-10-01
- Completion
- 2012-12-01
- First posted
- 2012-03-28
- Last updated
- 2014-07-10
Locations
1 site across 1 country: Chile
Source: ClinicalTrials.gov record NCT01565070. Inclusion in this directory is not an endorsement.